Form 4 for FTH Faeth Therapeutics, Inc.

Accepted 2022-03-09 00:00:00 ET · period of report 2022-03-08 · accession 0001209191-22-017684 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
DM	2022-03-09	2022-03-08	FTH	RINGO WILLIAM R	Dir	A - Grant	$0.00	+18.9K	18.9K	New	$0
D	2022-03-09	2022-03-08	FTH	RINGO WILLIAM R	Dir	A - Grant	$0.00	+29.1K	29.1K	New	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2022-03-08	A	A	8,933	$0.00	8,933	D	—	—	(F1) These shares represent restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in three equal annual installments on each of March 8, 2023, March 8, 2024, and March 8, 2025, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.
2	Common	Common Stock	2022-03-08	A	A	10,000	$0.00	18,933	D	—	—	(F2) These shares represent RSUs. Each RSU represents a contingent right to receive one share of the common stock of the Issuer. The shares underlying the RSUs vest in full on the first anniversary of the date of grant, on March 8, 2023, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date. (F3) Includes 8,933 shares acquired by the Reporting Person as of March 8, 2022 as an RSU award.
3	Derivative	Stock Option (Right to Buy)	2022-03-08	A	A	29,100	$0.00	29,100	D	$3.08 · — to 2032-03-07	29,100 Common Stock	(F4) The shares subject to the option vest monthly over thirty-six (36) months from the vesting commencement date, March 8, 2022, subject to the Reporting Person's continuous service with the Issuer as of each such vesting date.